Biblio Discovery — Demo Discovery Service

8 results for "Ya-Lin Chiu"

Showing 1–8 · 0.44 seconds · RSS

  1. Journal Article Full text

    Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial

    Marshall J. Glesby; Jeanine Albu; Ya-Lin Chiu et al.

    PLoS ONE, Vol. 8 No. 4 · 2013 · English · PLOS Scopus

    Background: Recombinant human growth hormone (rhGH) reduces visceral adipose tissue (VAT) volume in HIV-infected patients but can worsen glucose homeostasis and lipoatrophy. We aimed to determine if adding rosiglitazone to rhGH would abrogate the adverse effects of rhGH on insulin sensitivity (SI)…

    Also available at: DOAJ

  2. Journal Article Full text

    Dysregulated miR-361-5p/VEGF Axis in the Plasma and Endothelial Progenitor Cells of Patients with Coronary Artery Disease

    Hsei-Wei Wang; Hung-Hao Lo; Ya-Lin Chiu et al.

    PLoS ONE, Vol. 9 No. 5 · 2014 · English · PLOS Scopus

    Dysfunction and reduction of circulating endothelial progenitor cell (EPC) is correlated with the onset of cardiovascular disorders including coronary artery disease (CAD). VEGF is a known mitogen for EPC to migrate out of bone marrow to possess angiogenic activities, and the plasma levels of VEGF…

    Also available at: DOAJ

  3. Journal Article Full text

    MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation

    Hsei-Wei Wang; Shu-Han Su; Yen-Li Wang et al.

    PLOS ONE, Vol. 11 No. 1 · 2016 · English · PLOS Scopus

    Diabetes mellitus (DM) is a metabolic disease that is increasing worldwide. Furthermore, it is associated with the deregulation of vascular-related functions, which can develop into major complications among DM patients. Endothelial colony forming cells (ECFCs) have the potential to bring about…

    Also available at: DOAJ

  4. Journal Article

    Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

    Kyung Park; Scott A. Tomlins; Kumaran M. Mudaliar et al.

    Neoplasia: An International Journal for Oncology Research, Vol. 12 No. 7 · 2010 · English · DOAJ Scopus

    TMPRSS2-ERG gene fusions occur in 50% of prostate cancers and result in the overexpression of a chimeric fusion transcript that encodes a truncated ERG product. Previous attempts to detect truncated ERG products have been hindered by a lack of specific antibodies. Here, we characterize a rabbit…

  5. Journal Article

    SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts

    Mirjam Blattner; Daniel J. Lee; Catherine O'Reilly et al.

    Neoplasia: An International Journal for Oncology Research, Vol. 16 No. 1 · 2014 · English · DOAJ Scopus

    BACKGROUND: Recurrent mutations in the Speckle-Type POZ Protein (SPOP) gene occur in up to 15% of prostate cancers. However, the frequency and features of cancers with these mutations across different populations is unknown. OBJECTIVE: To investigate SPOP mutations across diverse cohorts and…